Edwards Lifesciences Corp Stock Price on January 30, 2024
EW Stock | USD 86.45 0.79 0.91% |
Below is the normalized historical share price chart for Edwards Lifesciences Corp extending back to March 27, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Edwards Lifesciences stands at 86.45, as last reported on the 19th of April, with the highest price reaching 87.35 and the lowest price hitting 85.98 during the day.
If you're considering investing in Edwards Stock, it is important to understand the factors that can impact its price. Edwards Lifesciences appears to be very steady, given 3 months investment horizon. Edwards Lifesciences Corp secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Edwards Lifesciences Corp, which you can use to evaluate the volatility of the firm. Please utilize Edwards Lifesciences' Mean Deviation of 1.38, downside deviation of 1.33, and Coefficient Of Variation of 796.11 to check if our risk estimates are consistent with your expectations.
At this time, Edwards Lifesciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 9.8 B in 2024, despite the fact that Other Stockholder Equity is likely to grow to (2.6 B). . At this time, Edwards Lifesciences' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to climb to 77.16 in 2024, whereas Price Earnings Ratio is likely to drop 31.34 in 2024. Edwards Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of March 2000 | 200 Day MA 78.7798 | 50 Day MA 89.947 | Beta 1.074 |
Edwards |
Sharpe Ratio = 0.1178
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | EW | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.1 actual daily | 18 82% of assets are more volatile |
Expected Return
0.25 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Edwards Lifesciences is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.
Price Book 8.1717 | Enterprise Value Ebitda 30.3262 | Price Sales 9.0498 | Shares Float 595.3 M | Wall Street Target Price 94.28 |
Edwards Lifesciences Valuation on January 30, 2024
It is possible to determine the worth of Edwards Lifesciences on a given historical date. On January 30, 2024 Edwards was worth 74.36 at the beginning of the trading date compared to the closed value of 73.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Edwards Lifesciences stock. Still, in general, we apply an absolute valuation method to find Edwards Lifesciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Edwards Lifesciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Edwards Lifesciences' related companies.
Open | High | Low | Close | Volume | |
72.98 | 74.62 | 72.71 | 74.57 | 2,683,396 | |
01/30/2024 | 74.36 | 74.48 | 73.68 | 73.90 | 2,118,650 |
77.76 | 79.93 | 77.19 | 78.47 | 9,470,520 |
Backtest Edwards Lifesciences | | | Edwards Lifesciences History | | | Edwards Lifesciences Valuation | Previous | Next |
Edwards Lifesciences Trading Date Momentum on January 30, 2024
On January 31 2024 Edwards Lifesciences Corp was traded for 78.47 at the closing time. The highest price during the trading period was 79.93 and the lowest recorded bid was listed for 77.19 . The volume for the day was 9.5 M. This history from January 31, 2024 contributed to the next trading day price increase. The overall trading delta to the next closing price was 6.18% . The overall trading delta to the current price is 16.48% . |
Edwards Lifesciences Corp Fundamentals Correlations and Trends
By evaluating Edwards Lifesciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Edwards financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Edwards Lifesciences Stock history
Edwards Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Edwards is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Edwards Lifesciences Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Edwards Lifesciences stock prices may prove useful in developing a viable investing in Edwards Lifesciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 609.4 M | 550.8 M | |
Net Income Applicable To Common Shares | 1.8 B | 1.8 B |
Edwards Lifesciences Quarterly Net Working Capital |
|
Edwards Lifesciences Stock Technical Analysis
Edwards Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Edwards Lifesciences Period Price Range
Low | January 30, 2024
| High |
74.36 | 73.90 |
Edwards Lifesciences April 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Edwards Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Edwards Lifesciences shares will generate the highest return on investment. By undertsting and applying Edwards Lifesciences stock market strength indicators, traders can identify Edwards Lifesciences Corp entry and exit signals to maximize returns
Accumulation Distribution | 22756.71 | |||
Daily Balance Of Power | (0.57) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 74.08 | |||
Day Typical Price | 74.02 | |||
Price Action Indicator | (0.41) | |||
Period Momentum Indicator | 12.55 | |||
Relative Strength Index | 79.0 |
Edwards Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Edwards Lifesciences' price direction in advance. Along with the technical and fundamental analysis of Edwards Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Edwards to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0846 | |||
Jensen Alpha | 0.2015 | |||
Total Risk Alpha | 0.0528 | |||
Sortino Ratio | 0.1404 | |||
Treynor Ratio | 0.3238 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.